Clinical Trial Update: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating catumaxomab in gastric cancer patients who received neoadjuvant chemotherapy and curative resection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Catumaxomab (Catumaxomab)

Snippet

Sponsor: Neovii Biotech | Conditions: Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | Status: COMPLETED